U.S. markets open in 2 hours 57 minutes

Karyopharm Therapeutics Inc. (KPTI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.33-0.04 (-0.48%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts10101010
Avg. Estimate-0.74-0.66-2.75-1.67
Low Estimate-0.85-0.77-3.08-2.22
High Estimate-0.64-0.49-2.21-1.18
Year Ago EPS-0.63-0.73-2.72-2.75
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts991010
Avg. Estimate25.64M30.29M121.92M219.43M
Low Estimate18.81M25.31M99.99M165M
High Estimate31.67M36M172.31M284.36M
Year Ago Sales33.51M21.33M108.08M121.92M
Sales Growth (year/est)-23.50%42.00%12.80%80.00%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.58-0.72-0.59-0.71
EPS Actual-0.63-0.73-0.59-0.77
Difference-0.05-0.010-0.06
Surprise %-8.60%-1.40%0.00%-8.50%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.74-0.66-2.75-1.67
7 Days Ago-0.74-0.66-2.74-1.64
30 Days Ago-0.74-0.66-2.74-1.64
60 Days Ago-0.73-0.65-2.72-1.65
90 Days Ago-0.62-0.51-2.23-0.92
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A111
Growth EstimatesKPTIIndustrySector(s)S&P 500
Current Qtr.-17.50%N/AN/AN/A
Next Qtr.9.60%N/AN/AN/A
Current Year-1.10%N/AN/AN/A
Next Year39.30%N/AN/AN/A
Next 5 Years (per annum)-30.30%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A